Skip to main content
Australian Prescriber logoLink to Australian Prescriber
letter
. 2020 Aug 1;43(4):113. doi: 10.18773/austprescr.2020.042

Fosfomycin and breastfeeding

PMCID: PMC7450774  PMID: 32921885
letter Aust Prescr. 2020 Aug 1;43(4):113.

Letter to the Editor

Tamara Lebedevs 1

A recent article on the treatment of resistant urinary tract infections stated that small amounts of fosfomycin are excreted in breast milk so it is not recommended in breastfeeding.1 Fosfomycin absorption is largely dependent on the salt form – trometamol salts are modestly absorbed (34–58%) and calcium salts are poorly absorbed (<12%). Fosfomycin secreted into human milk would likely be in the calcium form and is unlikely to be absorbed.

Foods and the acidic milieu of the stomach both significantly reduce oral absorption. Concentrations secreted into human milk have been reported to be about 10% of what is present in maternal plasma.2-6 It is not likely that the amount present in breast milk would produce untoward effects in a breastfeeding infant. On balance fosfomycin may be used with caution.

REFERENCES


Articles from Australian Prescriber are provided here courtesy of Therapeutic Guidelines Ltd

RESOURCES